October 4, 2017

What the FDA Reauthorization Act Means for Pharmaceuticals and Medical Devices

Signing document

On August 18th, President Trump signed the FDA Reauthorization Act (FDARA). Besides reauthorizing user fees for pharmaceuticals and medical devices for five years the law also focuses on many aspects of device regulation. (more…)

Categories:
Do you like it?0
September 28, 2017

Learn From Past Mistakes: Preparing For MDSAP And International Commercialization

Learn about some of the most common European regulatory compliance mistakes and how to avoid them.

 

Categories:
Do you like it?0
May 12, 2017

How Outsourced Regulatory Writing Can Benefit Your Organization

Thinking about using an outsourced regulatory writing team, but aren’t sure of the advantages?

In today’s medical device and pharmaceutical environment, it’s imperative to analyze and present complex information clearly and concisely while meeting critical timelines. Partnering with team of experienced regulatory writers can be a beneficial alternative to maintaining an in-house writing staff. (more…)

Categories:
Do you like it?0
May 12, 2017

New MEDDEV Guidelines: What You Need to Know

In July 2016, revision 4 of the MEDDEV 2.7/1 guidelines was released to much anticipation within the medical device community. The document has been expanded and now contains expanded details on requirements that effect almost every aspect of the clinical evaluation of medical devices with CE-mark. So what do you need to know to make sure your organization is in compliance? (more…)

Categories:
Do you like it?0